SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001079973-17-000366
Filing Date
2017-06-28
Accepted
2017-06-28 17:22:23
Documents
6
Period of Report
2017-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A opgen_8ka.htm 8-K/A 27495
2 EXHIBIT 3.1 ex3x1.htm EX-3.1 91993
3 EXHIBIT 4.1 ex4x1.htm EX-4.1 117561
4 EXHIBIT 10.1 ex10x1.htm EX-10.1 55482
5 EXHIBIT 10.2 ex10x2.htm EX-10.2 57753
6 EXHIBIT 10.3 ex10x3.htm EX-10.3 52790
  Complete submission text file 0001079973-17-000366.txt   404405
Mailing Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878
Business Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878 240-813-1260
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37367 | Film No.: 17936216
SIC: 8071 Services-Medical Laboratories